Vivos Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $3,820 | $3,016 | $3,698 | $3,860 |
Gross Profit | 2,110 | 1,509 | 2,097 | 2,334 |
EBITDA | -4,707 | -3,564 | -2,662 | -2,499 |
EBIT | -5,013 | -3,741 | -2,806 | -2,645 |
Net Income | -5,013 | -3,864 | -2,827 | -2,616 |
Net Change In Cash | 3,820 | 3,016 | 3,698 | 3,860 |
Free Cash Flow | -4,265 | -3,796 | -3,105 | -3,976 |
Cash | 4,402 | 2,342 | 6,260 | 6,311 |
Basic Shares | 9,087 | 8,595 | 5,889 | 6,615 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $15,031 | $13,801 | $16,024 | $16,885 |
Gross Profit | 9,019 | 8,271 | 10,019 | 12,604 |
EBITDA | -10,555 | -16,675 | -24,362 | -19,541 |
EBIT | -11,136 | -17,296 | -25,031 | -20,274 |
Net Income | -11,136 | -13,583 | -23,845 | -20,293 |
Net Change In Cash | 15,031 | 13,801 | 16,024 | 16,885 |
Free Cash Flow | -13,259 | -12,749 | -20,511 | -18,131 |
Cash | 6,260 | 1,643 | 3,519 | 24,030 |
Basic Shares | 5,019 | 1,219 | 920 | 849 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.55 |
2025-03-31 | -$0.48 |
2024-12-31 | -$0.28 |
